1,1'-[BIPHENYL-3,3'-DIYLBIS-(METHYLENE)]-BIS-[[4-(1,1-DIHYDROXYETHYL)]-ACETYLPYRIDINIUM]-DIBROMIDE
Compound with spectra: 1 NMR
![1,1'-[BIPHENYL-3,3'-DIYLBIS-(METHYLENE)]-BIS-[[4-(1,1-DIHYDROXYETHYL)]-ACETYLPYRIDINIUM]-DIBROMIDE](/api/compound/1hVX6v4HC5G.png?ph=true&h=300&w=458 "1,1'-[BIPHENYL-3,3'-DIYLBIS-(METHYLENE)]-BIS-[[4-(1,1-DIHYDROXYETHYL)]-ACETYLPYRIDINIUM]-DIBROMIDE")
| SpectraBase Compound ID | 1hVX6v4HC5G |
|---|---|
| InChI | InChI=1S/C28H30N2O4.2BrH/c1-27(31,32)25-9-13-29(14-10-25)19-21-5-3-7-23(17-21)24-8-4-6-22(18-24)20-30-15-11-26(12-16-30)28(2,33)34;;/h3-18,31-34H,19-20H2,1-2H3;2*1H/q+2;;/p-2 |
| InChIKey | WDFDVWPUAWUNAA-UHFFFAOYSA-L |
| Mol Weight | 618.366 g/mol |
| Molecular Formula | C28H30Br2N2O4 |
| Exact Mass | 616.057233 g/mol |
| Parent InChIKey | AVFMSGLFVIMMHU-UHFFFAOYSA-L |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD3OD |
3,16-Dithiatetracyclo[16.2.2.1(5,9).1(10,14)]tetracosa-5,7,9(24),10,12,14 (23),18,20,21-nonaene, 3,3,16,16-tetraoxide
(1,1':3',1"-terphenyl-4,4"-dimethyl)(1,1',3'-1"-terphenyl-3,3"-dimethyl)disulfide
N-methoxy-N-methyl-3-phenyl-benzamide
7,20-Dithiapentacyclo[20.2.2.2(2,5).1(9,13).1(14,18)]triaconta-2,4,9,11,13(28),14,16,18(27),22,24,25,29-dodecaene, 7,7,20,20-tetraoxide
1-[3'-(trifluoromethyl)biphenyl-3-yl]ethanone
3-(3-Methylphenyl)benzoic acid tert-butyl ester
3,3'-Dibenzoylbiphenyl
4-[3-[3-(Trifluoromethyl)phenyl]phenyl]benzenecarbonitrile
3-(3-pyridinyl)benzoic acid methyl ester
2-(m-BROMOBENZYL)ISOQUINOLINIUM BROMIDE
| Title | Journal or Book | Year |
|---|---|---|
| Quantitative structure–activity relationships for a series of symmetrical bisquaternary anticancer compounds | Bioorganic & Medicinal Chemistry | 2002 |